Volume 20, Number 7—July 2014
Letter
Carbapenemase-producing Klebsiella pneumoniae and Hematologic Malignancies
Livio Pagano
, Morena Caira, Enrico Maria Trecarichi, Teresa Spanu, Roberta Di Blasi, Simona Sica, Maurizio Sanguinetti, and Mario Tumbarello
, Morena Caira, Enrico Maria Trecarichi, Teresa Spanu, Roberta Di Blasi, Simona Sica, Maurizio Sanguinetti, and Mario Tumbarello
Table
Prevalence and attributable mortality rate of BSI, Rome, Italy, 2009–2012*
Year
Any gram-negative bacteria
Non-KPC–producing K. pneumoniae
KPC-producing K. pneumoniae
BSI, no.
Deaths, no. (%)
BSI, no.
Deaths, no. (%)
BSI, no.
Deaths, no. (%)
2009
30
5 (16.6)
1
0
0
0
2010
39
7 (17.9)
2
0
1
1 (100)
2011
41
9 (24.3)
5
1 (20)
13
7 (53.8)
2012
37
11 (29.7)
4
1 (25)
12
7 (58.3)
Total
147
32 (21.7)
12
2 (16.6)
26
15 (57.6)
*BSI, bloodstream infections; KPC, Klebsiella pneumoniae carbapenemase.
Page created: June 18, 2014
Page updated: June 18, 2014
Page reviewed: June 18, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.